The new Gammex 156D Stereotactic Mammographic Accreditation Phantom is designed to test the performance of digital mammographic systems currently used for stereotactic biopsy and localization by a quantitative evaluation of the system’s ability to image small structures similar to those found clinically.

The Gammex 156D can help determine if mammographic systems can detect small structures that are important in the early detection of cancer. The phantom is accredited by the American College of Radiology (ACR).

For more information: www.gammex.com


Additional Content

News | Artificial Intelligence

June 27, 2024 — The American College of Radiology (ACR) launched the ACR Recognized Center for Healthcare-AI (ARCH-AI) ...

Time June 27, 2024
arrow
News | Quality Assurance (QA)

November 25, 2023 — Mirion announced that it will debut the new Instadose VUE personal dosimeter, from its Dosimetry ...

Time November 25, 2023
arrow
News | Quality Assurance (QA)

March 16, 2023 — RTsafe, a leading provider of quality assurance products and services in stereotactic radiosurgery ...

Time March 16, 2023
arrow
News | Quality Assurance (QA)

October 7, 2022 — Mirion Technologies, Inc., a global provider of radiation detection, measurement, analysis and ...

Time October 07, 2022
arrow
News | Radiation Therapy

September 1, 2022 — IBA S.A., a leader in particle accelerator technology and a leader in dosimetry quality assurance ...

Time September 01, 2022
arrow
Subscribe Now